Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • INVO BioScience News

    0,9801 $ 0,00% +0,00 $
    In : 0,9137 € | 25.04.24 22:00:04 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3EJLW
    ISIN: US44984F4019
    US-Symbol: INVO
    Typ: Aktie

    INVO BioScience News

    09.02.22 - ACCESSWIRE
    INVO Bioscience Eyes +20 U.S. Cities To Expand Rollout Of Advanced Infertility Treatment 'INVO Centers'
    SAN FRANCISCO, CA / ACCESSWIRE / February 9, 2022 / Today, the global fertility market is a multi-​billion industry, yet remains severely underserved, with estimates suggesting ...
    14.07.21 - PR Newswire
    INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration
    INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration Joins INVO Bioscience to accelerate INVOcell's global OB/GYN clinical integration strategy PR ...
    30.06.21 - PR Newswire
    INVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an INVOcell Fertility Clinic in Atlanta
    INVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an INVOcell Fertility Clinic in Atlanta INVO Bioscience and established reproductive specialist Dr. Sue ...
    15.06.21 - PR Newswire
    INVO Bioscience Appoints Andrea Goren as Chief Financial Officer
    INVO Bioscience Appoints Andrea Goren as Chief Financial Officer PR Newswire
    17.05.21 - PR Newswire
    INVO Bioscience Reports First Quarter 2021 Financial and Operating Results and Provides Business Update
    INVO Bioscience Reports First Quarter 2021 Financial and Operating Results and Provides Business Update Company to Host Conference Call Today at 4:30pm ET (Details ...
    10.05.21 - PR Newswire
    INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for Global Brand Expansion
    INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for Global Brand Expansion Aggressive go-​to-market sales, partnerships, and marketing strategy to bring ...
    26.04.21 - PR Newswire
    INVO Bioscience Announces Appointment of Rebecca Messina to the Board of Directors
    INVO Bioscience Announces Appointment of Rebecca Messina to the Board of Directors Current Senior Advisor at McKinsey & Co. with strong expertise in global marketing and ...
    22.04.21 - PR Newswire
    INVO Bioscience Joins in Supporting RESOLVE: The National Infertility Association During its National Infertility Awareness Week (NIAW)
    INVO Bioscience Joins in Supporting RESOLVE: The National Infertility Association During its National Infertility Awareness Week (NIAW) - RESOLVE is a non-​profit action-​based, ...
    19.04.21 - PR Newswire
    INVO Bioscience Signs Partnership Agreement with Lyfe Medical to Establish INVOcell Clinic in Northern California
    INVO Bioscience Signs Partnership Agreement with Lyfe Medical to Establish INVOcell Clinic in Northern California - Approximately one in eight couples are affected by infertility in ...
    12.04.21 - PR Newswire
    INVO Bioscience to Present at Tribe Public Event on April 13, 2021
    INVO Bioscience to Present at Tribe Public Event on April 13, 2021 PR Newswire
    30.03.21 - PR Newswire
    INVO Bioscience Reports 2020 Financial Results
    INVO Bioscience Reports 2020 Financial Results Company to Host Conference Call on March 30 at 4:30pm ET (Details Below) PR Newswire
    29.03.21 - PR Newswire
    INVO Bioscience to Present at the Lytham Partners Spring 2021 Investor Conference
    INVO Bioscience to Present at the Lytham Partners Spring 2021 Investor Conference PR Newswire
    26.03.21 - PR Newswire
    INVO Bioscience to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Tuesday, March 30, 2021
    INVO Bioscience to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Tuesday, March 30, 2021 Financial results to be released after market close; Conference call ...
    16.03.21 - PR Newswire
    Thinking about buying stock in Invo Bioscience, Norwegian Cruise Line, Novan, Altimmune, or Transocean?
    Thinking about buying stock in Invo Bioscience, Norwegian Cruise Line, Novan, Altimmune, or Transocean? PR Newswire
    15.03.21 - PR Newswire
    INVO Bioscience Achieves Key Milestone - Signs Agreement to Open First Joint Venture INVOcell Clinic in the United States
    INVO Bioscience Achieves Key Milestone - Signs Agreement to Open First Joint Venture INVOcell Clinic in the United States INVO has partnered with experienced reproductive ...
    11.03.21 - PR Newswire
    INVO Bioscience to Participate in the 33rd Annual Roth Conference
    INVO Bioscience to Participate in the 33rd Annual Roth Conference PR Newswire
    10.03.21 - PR Newswire
    Thinking about buying stock in Altimmune, Invo Bioscience, Norwegian Cruise Line, ADC Therapeutics, or Clovis Oncology?
    Thinking about buying stock in Altimmune, Invo Bioscience, Norwegian Cruise Line, ADC Therapeutics, or Clovis Oncology? PR Newswire
    08.03.21 - PR Newswire
    INVO Bioscience Expands Company-Owned Clinic Opportunity Under Amended U.S. Commercialization Agreement
    INVO Bioscience Expands Company-​Owned Clinic Opportunity Under Amended U.S. Commercialization Agreement PR Newswire
    01.03.21 - PR Newswire
    INVO Bioscience Obtains Regulatory Approval to Import INVOcell Into Mexico
    INVO Bioscience Obtains Regulatory Approval to Import INVOcell Into Mexico PR Newswire

    Newssuche

    Videos

    newspaper
    25.04.24 +21,95%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »